Associations between lectin-like, oxidized low-density lipoprotein receptor-1 G501C and 3’-UTR-C188T polymorphisms with coronary artery disease: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 6, 2015, Pages 9275-9282

  Feng, Tian Ying ^a   Shan, Hong Wei ^b   Lang, Rui ^a  

^a INNER MONGOLIA PEOPLE S HOSPITAL   (China)

^b AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery disease; Lectin like; Meta analysis; Oxidized low density lipoprotein receptor 1; Polymorphism; SNP

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; META ANALYSIS; NONHUMAN; PROTEIN DEGRADATION; PUBLISHING; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84938340092     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. [1] Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, Sadowski Z, Golba KS, Prior DL, Rouleau JL and Bonow RO. Navigating the crossroads of coronary artery disease and heart failure. Circulation 2006; 114: 1202-1213.
2. [2] Libby P and Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111: 3481-3488.
3. [3] Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, Sawamura T, Masaki T, Hashimoto N and Kita T. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999; 99: 3110-3117.
4. [4] Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Zimmer EL, McNamara DM, Pauly DF, Sharaf B, Holubkov R, Bairey Merz CN, Sopko G, Bontempo F and Kamboh MI. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation 2003; 107: 3146-3151.
5. [5] Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R, Mehta JL, Novelli G and Romeo F. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 2003; 40: 933-936.
6. [6] Tatsuguchi M, Furutani M, Hinagata J, Tanaka T, Furutani Y, Imamura S, Kawana M, Masaki T, Kasanuki H, Sawamura T and Matsuoka R. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 2003; 303: 247-250.
7. [7] Ohmori R, Momiyama Y, Nagano M, Taniguchi H, Egashira T, Yonemura A, Nakamura H, Kondo K and Ohsuzu F. An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol 2004; 27: 641-644.
8. [8] Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 28.
9. [9] MANTEL N, HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
10. [10] DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
11. [11] Tobias A. Assessing the influence of a single study in the meta-analytic estimate. Stata Technical Bulletin Reprints 1999; 8: 2.
12. [12] Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
13. [13] Trabetti E, Biscuola M, Cavallari U, Malerba G, Girelli D, Olivieri O, Martinelli N, Corrocher R and Pignatti PF. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet 2006; 14: 127-130.
14. [14] Predazzi IM, Martinez-Labarga C, Vecchione L, Mango R, Ciccacci C, Amati F, Ottoni C, Crawford MH, Rickards O, Romeo F and Novelli G. Population differences in allele frequencies at the OLR1 locus may suggest geographic disparities in cardiovascular risk events. Ann Hum Biol 2010; 37: 136-148.
15. [15] Knowles JW, Assimes TL, Boerwinkle E, Fortmann SP, Go A, Grove ML, Hlatky M, Iribarren C, Li J, Myers R, Risch N, Sidney S, Southwick A, Volcik KA and Quertermous T. Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. BMC Med Genet 2008; 9: 23.
16. [16] Kurnaz O, Aydogan HY, Isbir CS, Tekeli A and Isbir T. Is LOX-1 K167N polymorphism protective for coronary artery disease? In Vivo 2009; 23: 969-973.
17. Novelli G, Borgiani P, Mango R, Lauro R and Romeo F. Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction. Nutr Metab Cardiovasc Dis 2007; 17: e7-8; author reply e9-10.
18. [18] Morgan TM, Krumholz HM, Lifton RP and Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 2007; 297: 1551-1561.
19. [19] Tuten A, Aydemir B, Oncul M, Kiziler AR, Acikgoz AS, Korkmaz GG, Sozer V and Uzun H. The association of lectin-like oxidized LDL receptor 1 (LOX-1) K167N and 3’UTR188CT polymorphisms with maternal plasma soluble LOX-1 levels and preeclampsia risk in Turkish population. Arch Gynecol Obstet 2015; 291: 563-571.
20. [20] Kurnaz O, Akadam-Teker AB, Yilmaz-Aydogan H, Tekeli A and Isbir T. The LOX-1 3’UTR188CT polymorphism and coronary artery disease in Turkish patients. Mol Biol Rep 2012; 39: 4351-4358.
21. [21] Qiang H ZZ, Liu P. Association of polymorphism of LOX-1 3-UTR+1073 with coronary heart disease in Chinese population. Chin Heart J 2007; 2.
22. [22] Su L MY, Yan Z. Relationship between gene polymorphism of LOX-1 and coronary artery disease in elderly Chinese Han population. Chin J Geriatr Heart Brain Vessel 2011; 13: 3.
23. [23] Dou J LY, Gao J. Correlation between Polymorphism of 3’-UTR of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Gene and Coronary Artery Disease in Tianjin Population. Tianjin Med J 2012; 40.
24. [24] Zhou JB XL, Yang X. Negative Association Belween Variants of LOX-1 Gene and Coronary Artery Disease in Han Population of Eastern Area of Zhejiang Province. J Med Res 2012; 41.
25. [25] Vecchione L, Gargiul E, Borgiani P, Predazzi I, Mango R, Romeo F, Magnani M and Novelli G. Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2007; 2: 147-151.
26. [26] Li D, Williams V, Liu L, Chen H, Sawamura T, Antakli T and Mehta JL. LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol 2002; 283: H1795-1801.
27. [27] Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, Sawamura T and Mehta JL. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res 2008; 79: 287-293.
28. [28] Hirschhorn JN, Lohmueller K, Byrne E and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 45-61.
29. [29] Zhang H, Xu Y, Zhang Z, Liu R and Ma B. Association between COX-2 rs2745557 polymorphism and prostate cancer risk: A systematic review and meta-analysis. BMC Immunol 2012; 13: 14.
30. [30] Guan Fook Ng N-AZ, Bakiah S, Liza-Sharmini AT. A comparative study of retinal nerve fiber layer thickness (RNFL) among different sub-ethnic groups of Malay. International Medical Journa 2012; 19: 4.